188 related articles for article (PubMed ID: 9396810)
1. Effects of heterologous downstream sequences on the activity of the HIV-1 promoter and its response to Tat.
Greenberg ME; Mathews MB
Nucleic Acids Res; 1997 Dec; 25(24):5017-24. PubMed ID: 9396810
[TBL] [Abstract][Full Text] [Related]
2. Transactivation of heterologous promoters by HIV-1 tat.
Han P; Brown R; Barsoum J
Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
Roebuck KA; Rabbi MF; Kagnoff MF
AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
[TBL] [Abstract][Full Text] [Related]
5. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
[TBL] [Abstract][Full Text] [Related]
6. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression.
Lisziewicz J; Rappaport J; Dhar R
New Biol; 1991 Jan; 3(1):82-9. PubMed ID: 2039768
[TBL] [Abstract][Full Text] [Related]
7. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
Robinson D; Elliott JF; Chang LJ
Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
[TBL] [Abstract][Full Text] [Related]
8. Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin.
Verhoef K; Tijms M; Berkhout B
Nucleic Acids Res; 1997 Feb; 25(3):496-502. PubMed ID: 9016587
[TBL] [Abstract][Full Text] [Related]
9. Cellular and viral specificity of equine infectious anemia virus Tat transactivation.
Maury WJ; Carpenter S; Graves K; Chesebro B
Virology; 1994 May; 200(2):632-42. PubMed ID: 8178449
[TBL] [Abstract][Full Text] [Related]
10. Cellular factors regulate transactivation of human immunodeficiency virus type 1.
Barry PA; Pratt-Lowe E; Unger RE; Luciw PA
J Virol; 1991 Mar; 65(3):1392-9. PubMed ID: 1995949
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
[TBL] [Abstract][Full Text] [Related]
12. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
Rhim H; Rice AP
Nucleic Acids Res; 1994 Oct; 22(21):4405-13. PubMed ID: 7971271
[TBL] [Abstract][Full Text] [Related]
13. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
Kamine J; Subramanian T; Chinnadurai G
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
[TBL] [Abstract][Full Text] [Related]
14. Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity.
Kliewer S; Garcia J; Pearson L; Soultanakis E; Dasgupta A; Gaynor R
J Virol; 1989 Nov; 63(11):4616-25. PubMed ID: 2529378
[TBL] [Abstract][Full Text] [Related]
15. TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter.
Berkhout B; Gatignol A; Rabson AB; Jeang KT
Cell; 1990 Aug; 62(4):757-67. PubMed ID: 2201451
[TBL] [Abstract][Full Text] [Related]
16. Purification and functional characterization of wild-type and mutant HIV-1 and HIV-2 Tat proteins expressed in Escherichia coli.
Orsini MJ; García-Martínez LF; Mavankal G; Gaynor RB; Debouck CM
Protein Expr Purif; 1996 Sep; 8(2):238-46. PubMed ID: 8812870
[TBL] [Abstract][Full Text] [Related]
17. New human gene encoding a positive modulator of HIV Tat-mediated transactivation.
Shibuya H; Irie K; Ninomiya-Tsuji J; Goebl M; Taniguchi T; Matsumoto K
Nature; 1992 Jun; 357(6380):700-2. PubMed ID: 1377363
[TBL] [Abstract][Full Text] [Related]
18. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.
Scala G; Ruocco MR; Ambrosino C; Mallardo M; Giordano V; Baldassarre F; Dragonetti E; Quinto I; Venuta S
J Exp Med; 1994 Mar; 179(3):961-71. PubMed ID: 8113688
[TBL] [Abstract][Full Text] [Related]
19. TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation.
Taylor JP; Pomerantz R; Bagasra O; Chowdhury M; Rappaport J; Khalili K; Amini S
EMBO J; 1992 Sep; 11(9):3395-403. PubMed ID: 1505523
[TBL] [Abstract][Full Text] [Related]
20. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.
Graham GJ; Maio JJ
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5817-21. PubMed ID: 1696012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]